• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺睾丸癌中的核蛋白。

Nuclear protein in testis carcinoma of the lung.

作者信息

Chen Jing, Li Meihui, Lu Hongyang

机构信息

Zhejiang Key Laboratory of Diagnosis & Treatment Technology on Thoracic Oncology (lung and esophagus), Zhejiang Cancer Hospital, Institute of Basic and Cancer Medicine (IBCM), 310022, P.R. China; Department of Thoracic Medical Oncology, Zhejiang Cancer Hospital, Institute of Basic and Cancer Medicine (IBCM), 310022, P.R. China; Wenzhou Medical University, Wenzhou, 325035, P.R. China.

Zhejiang Key Laboratory of Diagnosis & Treatment Technology on Thoracic Oncology (lung and esophagus), Zhejiang Cancer Hospital, Institute of Basic and Cancer Medicine (IBCM), 310022, P.R. China; Department of Thoracic Medical Oncology, Zhejiang Cancer Hospital, Institute of Basic and Cancer Medicine (IBCM), 310022, P.R. China; The First Clinical Medical College, Wenzhou Medical University, Wenzhou, 325035, P.R. China.

出版信息

Transl Oncol. 2023 Apr;30:101640. doi: 10.1016/j.tranon.2023.101640. Epub 2023 Feb 11.

DOI:10.1016/j.tranon.2023.101640
PMID:36780749
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9947104/
Abstract

Nuclear protein in testis (NUT) carcinoma is a kind of highly aggressive and fatal solid tumor characterized by a rearrangement of the NUT carcinoma family member 1 (NUTM1) gene located on chromosome 15 q l4, where the most common form of fusion is BRD4-NUT. NUT carcinoma occurred in different organs and was most commonly found in the midline organs and the lungs. NUT carcinoma can occur in patients of almost all ages, having a roughly consistent incidence in both sexes. Most of the patients were diagnosed in advanced stages with an extremely poor prognosis due to the lack of effective treatment. After years of research, the mechanism of NUT carcinoma is still not fully clear, and its therapeutic approaches need to be further studied and explored. In order to gain a more comprehensive understanding of NUT carcinoma and explore the effective treatments, this review aimed to summarize the clinical features, pathological characteristics, differential diagnosis, and treatment strategies for this disease.

摘要

睾丸核蛋白(NUT)癌是一种高度侵袭性和致命性的实体瘤,其特征是位于15号染色体q14上的NUT癌家族成员1(NUTM1)基因发生重排,最常见的融合形式是BRD4-NUT。NUT癌发生于不同器官,最常见于中线器官和肺部。NUT癌几乎可发生于所有年龄段的患者,男女发病率大致相当。由于缺乏有效治疗,大多数患者在晚期被诊断出来,预后极差。经过多年研究,NUT癌的发病机制仍不完全清楚,其治疗方法有待进一步研究和探索。为了更全面地了解NUT癌并探索有效的治疗方法,本综述旨在总结该疾病的临床特征、病理特征、鉴别诊断和治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2423/9947104/58b4ec6769b1/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2423/9947104/58b4ec6769b1/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2423/9947104/58b4ec6769b1/ga1.jpg

相似文献

1
Nuclear protein in testis carcinoma of the lung.肺睾丸癌中的核蛋白。
Transl Oncol. 2023 Apr;30:101640. doi: 10.1016/j.tranon.2023.101640. Epub 2023 Feb 11.
2
NUT Carcinoma: Clinicopathologic Features, Molecular Genetics and Epigenetics.NUT癌:临床病理特征、分子遗传学与表观遗传学
Front Oncol. 2022 Mar 16;12:860830. doi: 10.3389/fonc.2022.860830. eCollection 2022.
3
[Research Progress on Pathogenesis and Treatment of NUT Carcinoma].[NUT癌的发病机制与治疗研究进展]
Zhongguo Fei Ai Za Zhi. 2024 Jun 20;27(6):466-470. doi: 10.3779/j.issn.1009-3419.2024.101.16.
4
Clinical and molecular features of pulmonary NUT carcinoma characterizes diverse responses to immunotherapy, with a pathologic complete response case.肺 NUT 癌的临床和分子特征表现出对免疫治疗的多样化反应,其中包括一例病理完全缓解病例。
J Cancer Res Clin Oncol. 2023 Aug;149(9):6361-6370. doi: 10.1007/s00432-023-04621-5. Epub 2023 Feb 8.
5
BRD3-NUTM1-expressing NUT carcinoma of lung on endobronchial ultrasound-guided transbronchial needle aspiration cytology, a diagnostic pitfall.经支气管超声引导经支气管针吸活检术(EBUS-TBNA)细胞学检查中,BRD3-NUTM1 表达的肺 NUT 癌:一个诊断陷阱。
Diagn Cytopathol. 2022 Feb;50(2):E47-E53. doi: 10.1002/dc.24885. Epub 2021 Oct 21.
6
The first report of molecular characterized BRD4-NUT carcinoma in Brazil: a case report.巴西首例分子特征明确的BRD4-NUT癌病例报告
J Med Case Rep. 2019 Sep 7;13(1):279. doi: 10.1186/s13256-019-2213-6.
7
Thoracic NUT carcinoma: Common pathological features despite diversity of clinical presentations.胸内 NUT 癌:临床表现多样,但具有共同的病理特征。
Lung Cancer. 2021 Aug;158:55-59. doi: 10.1016/j.lungcan.2021.06.008. Epub 2021 Jun 8.
8
Primary Thyroid NUT Carcinoma With High PD-L1 Expression and Novel Massive Gene Fusions: A Case Report With Treatment Implications and Literature Review.原发性甲状腺 NUT 癌伴高 PD-L1 表达及新型大量基因融合:1 例报告及治疗启示与文献综述
Front Oncol. 2022 Jan 19;11:778296. doi: 10.3389/fonc.2021.778296. eCollection 2021.
9
Thyroid Carcinoma with NSD3::NUTM1 Fusion: a Case with Thyrocyte Differentiation and Colloid Production.甲状腺癌伴 NSD3::NUTM1 融合:具有甲状腺细胞分化和胶体产生的病例。
Endocr Pathol. 2022 Jun;33(2):315-326. doi: 10.1007/s12022-021-09700-2. Epub 2022 Jan 8.
10
A 47-year-old woman with nuclear protein in testis midline carcinoma masquerading as a sinus infection: a case report and review of the literature.一名47岁伪装成鼻窦感染的睾丸中线核蛋白癌女性病例报告及文献复习
J Med Case Rep. 2019 Mar 11;13(1):57. doi: 10.1186/s13256-019-2015-x.

引用本文的文献

1
Pulmonary Nuclear protein in Testis (NUT) carcinoma: clinical, molecular characteristics, and treatment strategies.肺睾丸核蛋白(NUT)癌:临床、分子特征及治疗策略
BMC Cancer. 2025 Feb 4;25(1):196. doi: 10.1186/s12885-025-13593-3.
2
Primary pulmonary nuclear protein of the testis midline carcinoma: case report and systematic review with pooled analysis.睾丸中线癌的原发性肺核蛋白:病例报告及汇总分析的系统评价
Front Oncol. 2024 Jan 9;13:1308432. doi: 10.3389/fonc.2023.1308432. eCollection 2023.
3
Beyond liver cancer, more application scenarios for alpha-fetoprotein in clinical practice.

本文引用的文献

1
Diagnosis, Treatment and Prognosis of Primary Pulmonary NUT Carcinoma: A Literature Review.原发性肺 NUT 癌的诊断、治疗与预后:文献综述。
Curr Oncol. 2022 Sep 22;29(10):6807-6815. doi: 10.3390/curroncol29100536.
2
SMARCA4-deficient undifferentiated tumor that responded to chemotherapy in combination with immune checkpoint inhibitors: A case report.SMARCA4 缺陷型未分化肿瘤对化疗联合免疫检查点抑制剂有反应:病例报告。
Thorac Cancer. 2022 Aug;13(15):2264-2266. doi: 10.1111/1759-7714.14547. Epub 2022 Jul 2.
3
NUT Carcinoma: Clinicopathologic Features, Molecular Genetics and Epigenetics.
除了肝癌,甲胎蛋白在临床实践中还有更多的应用场景。
Front Oncol. 2023 Sep 15;13:1231420. doi: 10.3389/fonc.2023.1231420. eCollection 2023.
NUT癌:临床病理特征、分子遗传学与表观遗传学
Front Oncol. 2022 Mar 16;12:860830. doi: 10.3389/fonc.2022.860830. eCollection 2022.
4
NUT midline lung cancer: a rare case report with literature review.NUT中线肺癌:一例罕见病例报告并文献复习
AME Case Rep. 2022 Jan 25;6:2. doi: 10.21037/acr-21-35. eCollection 2022.
5
NUT midline carcinoma as a primary lung tumor treated with anlotinib combined with palliative radiotherapy: a case report.NUT 中线癌作为原发性肺肿瘤,采用安罗替尼联合姑息性放疗治疗:一例报告。
Diagn Pathol. 2022 Jan 7;17(1):4. doi: 10.1186/s13000-021-01188-y.
6
Immunotherapy and Targeting the Tumor Microenvironment: Current Place and New Insights in Primary Pulmonary NUT Carcinoma.免疫疗法与肿瘤微环境靶向治疗:原发性肺NUT癌的现状与新见解
Front Oncol. 2021 Sep 30;11:690115. doi: 10.3389/fonc.2021.690115. eCollection 2021.
7
Misleading Germ Cell Phenotype in Pulmonary NUT Carcinoma Harboring the ZNF532-NUTM1 Fusion.肺 NUT 癌中 ZNF532-NUTM1 融合导致的误导性生殖细胞表型。
Am J Surg Pathol. 2022 Feb 1;46(2):281-288. doi: 10.1097/PAS.0000000000001774.
8
NUT carcinoma of the lung.肺 NUT 癌。
Semin Diagn Pathol. 2021 Sep;38(5):72-82. doi: 10.1053/j.semdp.2021.06.005. Epub 2021 Jun 16.
9
Recent updates in thoracic SMARCA4-deficient undifferentiated tumor.胸部 SMARCA4 缺陷型未分化肿瘤的最新进展。
Semin Diagn Pathol. 2021 Sep;38(5):83-89. doi: 10.1053/j.semdp.2021.06.001. Epub 2021 Jun 4.
10
Supercharging BRD4 with NUT in carcinoma.BRD4 在癌中的 NUT 超驱动。
Oncogene. 2021 Feb;40(8):1396-1408. doi: 10.1038/s41388-020-01625-0. Epub 2021 Jan 15.